Risks and Indications
Patients undergoing radiofrequency ablation are subject to risks associated with surgery including complications from anesthesia/sedation, as well as bleeding, bruising, pain and infection. Additional complications could include: blood clots, collapsed lungs, and damage to normal tissue, nerves, the spinal cord or other structures resulting in injuries including paralysis.
The STAR Tumor Ablation System does not treat cancer. It is indicated for palliative treatment (i.e., pain relief) in spinal procedures by ablation of metastatic malignant lesions in a vertebral body.
The STAR Tumor Ablation System is contraindicated for:
• lesions in the cervical levels of the spine.
• patients with pacemakers or other electronic implants.
Not every patient is a candidate for t-RFA.
Treating Metastatic Spinal Tumors with the targeted Radiofrequency Ablation (t-RFA) Procedure
Providing fast and lasting relief from painful metastatic spinal lesions is now possible with minimally invasive targeted radiofrequency ablation (t-RFA) procedure.
The t-RFA procedure offers dramatic improvements in the palliative treatment of metastatic spinal tumors. Conventional methods can take weeks and require multiple treatments to achieve meaningful pain reductions. By comparison, t-RFA procedures have been shown to provide patients with meaningful pain relief that is both rapid and durable.
Combining controlled access to the vertebral body with controlled RF energy delivery, the STAR Tumor Ablation System create a controlled RF ablation zone. This offers physicians the ability to reduce the size and symptoms of metastatic spinal tumors in a single, minimally invasive t-RFA procedure.
Unlike patients treated with conventional radiation therapy, those patients who undergo a t-RFA procedure to treat metastatic spinal tumors may not need to delay systemic and primary cancer treatment regimens.